Vesicare Yamanouchi / GlaxoSmithKline - Treatment for Overactive Bladder

Vesicare is a muscarinic receptor antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urgency, frequency, and urge incontinence.

Posted: November 2004

VESIcare (solifenacin) FDA Approval History

View comments

Hide
(web3)